{
    "eid": "2-s2.0-85089566670",
    "title": "Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: A critical perspective review",
    "cover-date": "2020-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Antioxidants",
        "Inflammation",
        "Neuroimmunomodulation",
        "Nutrition",
        "Oxidative stress",
        "Parkinson's disease"
    ],
    "authors": [
        "Geir Bj\u00f8rklund",
        "Maryam Dadar",
        "George Anderson",
        "Salvatore Chirumbolo",
        "Michael Maes"
    ],
    "citedby-count": 15,
    "ref-count": 164,
    "ref-list": [
        "Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?",
        "Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study",
        "Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected",
        "Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment",
        "Alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration",
        "Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease",
        "Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation",
        "The epidemiology of Parkinson's disease: risk factors and prevention",
        "Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention",
        "Oxidative stress and Parkinson's disease",
        "The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability",
        "Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens",
        "Identification of a highly neurotoxic \u03b1-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease",
        "Phenothiazine normalizes the NADH/NAD+ ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease",
        "The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis",
        "Molecular Mechanism of the Relation of Monoamine Oxidase B and Its Inhibitors to Parkinson's Disease: Possible Implications of Glial Cells, Oxidative Stress and Neuroprotection",
        "Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson's disease?",
        "Genetic silencing of fatty acid desaturases modulates \u03b1-synuclein toxicity and neuronal loss in Parkinson-like models of C. elegans",
        "Robot-based assessment of sitting and standing balance: preliminary results in Parkinson's disease",
        "Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson's",
        "Effects of dual-task aquatic exercises on functional mobility, balance and gait of individuals with Parkinson's disease: a randomized clinical trial with a 3-month follow-up",
        "Prevention of progression in Parkinson's disease",
        "Does vigorous exercise have a neuroprotective effect in Parkinson disease?",
        "Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models",
        "Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer's disease and Parkinson's disease",
        "Rosenroot (Rhodiola): potential applications in aging-related diseases",
        "Gami-chunggan formula prevents motor dysfunction in MPTP/p-induced and A53T \u03b1-synuclein overexpressed Parkinson's disease mouse model though DJ-1 and BDNF expression",
        "Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?",
        "Advances in the research of risk factors and prodromal biomarkers of Parkinson's disease",
        "Meta-analytic methodology for basic research: a practical guide",
        "Lipid peroxidation products and their role in neurodegenerative diseases",
        "Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: disease and staging biomarkers and new drug targets",
        "Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients",
        "Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population",
        "Lowered iPLA2\u03b3 activity causes increased mitochondrial lipid peroxidation and mitochondrial dysfunction in a rotenone-induced model of Parkinson's disease",
        "Oxidative stress in Parkinson's disease",
        "Mitochondrial dysfunction in Parkinson's disease",
        "Protein Oxidation, Quality-Control Mechanisms and Parkinson's Disease, Oxidative Stress and Redox Signalling in Parkinson's Disease",
        "Regulation of pyruvate dehydrogenase kinase 4 in the heart through degradation by the Lon protease in response to mitochondrial substrate availability",
        "Mitochondria and the Gut as crucial hubs for the interactions of melatonin with sirtuins, inflammation, butyrate, tryptophan metabolites, and alpha 7 nicotinic receptor across a host of medical conditions",
        "Gut permeability and microbiota in Parkinson's disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways",
        "Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins",
        "Mitochondrial associated metabolic proteins are selectively oxidized in A30P \u03b1-synuclein transgenic mice\u2014a model of familial Parkinson's disease",
        "Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons",
        "Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra",
        "AAA proteases: cellular machines for degrading membrane proteins",
        "Mitochondrial creatine kinase is decreased in the serum of idiopathic Parkinson's disease patients",
        "Alzheimer's disease and Parkinson's disease: a nutritional toxicology perspective of the impact of oxidative stress, mitochondrial dysfunction, nutrigenomics and environmental chemicals",
        "Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment",
        "Riboflavin responsive mitochondrial dysfunction in neurodegenerative diseases",
        "PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress",
        "Melatonin reverses the oxidative stress and mitochondrial dysfunction caused by LETM1 silencing",
        "Mdm38 is a 14-3-3-like receptor and associates with the protein synthesis machinery at the inner mitochondrial membrane",
        "Relatively high mortality risk in elderly Swedish subjects with low selenium status",
        "An Essay on the Shaking Palsy (London: Sherwood, Neely and Jones)",
        "Ceramides in Parkinson's disease: from recent evidence to new hypotheses",
        "Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells",
        "GM1 ganglioside modifies \u03b1-synuclein toxicity and is neuroprotective in a rat \u03b1-synuclein model of parkinson's disease",
        "Sodium butyrate causes \u03b1-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway",
        "Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease",
        "Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease",
        "The role of IRE1 signaling in the central nervous system diseases",
        "Hydroxyurea facilitates manifestation of disease relevant phenotypes in patients-derived IPSCs-based modeling of late-onset Parkinson's disease",
        "Cholinesterase and homocysteine: potential predictors for Parkinson's disease dementia and vascular parkinsonism dementia in advanced stage",
        "D.I. Parkinson study group, vitamin B12 and homocysteine levels predict different outcomes in early Parkinson's disease",
        "Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study",
        "Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study",
        "High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced beta-catenin-mediated activity",
        "Meta-analysis of early nonmotor features and risk factors for Parkinson disease",
        "Parkinson's disease and tea: a quantitative review",
        "Caffeine for treatment of Parkinson disease: a randomized controlled trial",
        "Association of coffee and caffeine intake with the risk of Parkinson disease",
        "Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A 2A receptors",
        "Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studiess",
        "Dose\u2013response meta-analysis on coffee, tea and caffeine consumption with risk of P arkinson's disease",
        "Iron-chelation properties of phenolic acids bearing catechol and galloyl groups",
        "Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450 (CYP) 1A2",
        "Melatonin and Parkinson disease: current status and future perspectives for molecular mechanisms",
        "The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice",
        "Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson's disease induced by rotenone",
        "Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: an evidence based affirmative from a comparative analysis of behavior and biomarker expression",
        "Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB",
        "Extracranial arterial wall volume is increased and shows relationships with vascular MRI measures in idiopathic Parkinson's disease",
        "Caffeine enhances heart rate variability in middle-aged healthy, but not heart failure subjects",
        "Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease",
        "Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease",
        "(1)H NMR profiling of the 6-OHDA parkinsonian rat brain reveals metabolic alterations and signs of recovery after N-acetylcysteine treatment",
        "Repeated-dose oral N-acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress",
        "N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities",
        "N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease",
        "N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: an investigation into the interaction of parkin and Drp1 proteins",
        "Up-regulation of \u03b3-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease",
        "Repeated-dose oral N-Acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress",
        "N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1\u2212/\u2212 mouse",
        "Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease",
        "Cytotoxic and genotoxic potential of dopamine",
        "Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease",
        "Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones",
        "Central nervous system uptake of intranasal glutathione in Parkinson's disease",
        "Reduced intravenous glutathione in the treatment of early Parkinson's disease",
        "Glutathione",
        "Selenium: biochemical role as a component of glutathione peroxidase",
        "The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution",
        "Glutathione peroxidase family\u2013an evolutionary overview",
        "Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain",
        "Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine",
        "Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease",
        "The time-trend and the relation between smoking and circulating selenium concentrations in Norway",
        "Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens",
        "Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation",
        "Ten metal complexes of vitamin B3/niacin: spectroscopic, thermal, antibacterial, antifungal, cytotoxicity and antitumor studies of Mn (II), Fe (III), Co (II), Ni (II), Cu (II), Zn (II), Pd (II), Cd (II), Pt (IV) and Au (III) complexes",
        "Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism",
        "A novel treatment target for Parkinson's disease",
        "Niacin ameliorates neuro-inflammation in Parkinson's disease via GPR109A",
        "Upregulation of GPR109A in Parkinson's disease",
        "Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis",
        "Pharmacology",
        "Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans",
        "Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: a translational meta-analysis of rodent and human studies",
        "Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice",
        "Mitochondria express \u03b17 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria",
        "Passive smoking and Parkinson disease",
        "Active and passive smoking and risk of Parkinson's disease",
        "Passive smoking and Parkinson's disease in California teachers",
        "Meta-analysis of the acute effects of nicotine and smoking on human performance",
        "Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+",
        "The effects of nicotine on Parkinson's disease",
        "Smoking, nicotine and Parkinson's disease",
        "Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease",
        "History of falls in Parkinson disease is associated with reduced cholinergic activity",
        "Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas",
        "Melatonin transport into mitochondria",
        "Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?",
        "Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor\u2013dependent pathway in rats in vivo",
        "Melatonin improves behavioral and biochemical outcomes in a rotenone-induced rat model of Parkinson's Disease",
        "Melatonin MT1 and MT2 receptor expression in Parkinson's disease",
        "Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units",
        "Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease",
        "Increased serum cystatin C in early Parkinson's disease with objective sleep disturbances",
        "Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair",
        "Pharmacological targeting of beta2 -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease",
        "Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases",
        "Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease",
        "Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease",
        "Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study",
        "NSAID use and risk of Parkinson disease: a population-based case-control study",
        "Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis",
        "Novel anti-inflammatory therapy for Parkinson's disease",
        "Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs",
        "Inhibition of Nwd1 activity attenuates neuronal hyperexcitability and GluN2B phosphorylation in the hippocampus",
        "Modulation and functions of dopamine receptor heteromers in drugs of abuse-induced adaptations",
        "Contra-directional coupling of Nur77 and Nurr1 in neurodegeneration: a novel mechanism for memantine-induced anti-inflammation and anti-mitochondrial impairment",
        "Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses",
        "Nurr1-based therapies for Parkinson's disease",
        "The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis",
        "The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease",
        "Could heat therapy be an effective treatment for alzheimer's and parkinson's diseases? A narrative review",
        "Role of heat shock proteins 70/90 in exercise physiology and exercise immunology and their diagnostic potential in sports",
        "Plasma lipoprotein-associated phospholipase A2 and superoxide dismutase are independent predicators of cognitive impairment in cerebral small vessel disease patients: diagnosis and assessment",
        "Non-motor Symptoms of Parkinson's Disease",
        "Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial",
        "Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)",
        "Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: a valuable tool for evaluating progressive supranuclear palsy",
        "Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: a prospective study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Mo i Rana",
            "@id": "60158097",
            "affilname": "Council for Nutritional and Environmental Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60158097",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Karaj",
            "@id": "60089309",
            "affilname": "Razi Vaccine &amp; Serum Research Institute, Iran",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60089309",
            "affiliation-country": "Iran"
        },
        {
            "affiliation-city": "Verona",
            "@id": "60032256",
            "affilname": "Universit\u00e0 degli Studi di Verona",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032256",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Verona",
            "@id": "124333557",
            "affilname": "CONEM Scientific Secretary",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124333557",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "London",
            "@id": "118816340",
            "affilname": "CRC Scotland &amp; London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118816340",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}